Stay updated on Reslizumab in EGPA: Clinical Trial

Sign up to get notified when there's something new on the Reslizumab in EGPA: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Reslizumab in EGPA: Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changed from v3.7.0 to v3.7.1 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-07T00:38:07.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, blocking access to the record and replacing the previous study details with a standard error page.
    Difference
    17%
    Check dated 2026-09-23T00:42:17.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The label for locating contact information was updated from 'Find Contact Information' to 'Find contact information', and the page revision was updated from v3.6.6 to v3.7.0, indicating a small update to the page metadata.
    Difference
    0.1%
    Check dated 2026-09-15T23:43:36.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The revision label changed from v3.6.5 to v3.6.6, indicating a new version of the page template. This appears to be an internal update rather than a substantive change to page content.
    Difference
    0.1%
    Check dated 2026-09-01T19:33:52.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.4 to v3.6.5, indicating a minor site update that does not change the study details shown on the page.
    Difference
    0.1%
    Check dated 2026-08-11T18:25:17.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Revision updated from v3.6.3 to v3.6.4, indicating a new page/version release. No visible study content changes are described in the provided data.
    Difference
    0.1%
    Check dated 2026-07-28T11:31:20.000Z thumbnail image

Stay in the know with updates to Reslizumab in EGPA: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Reslizumab in EGPA: Clinical Trial page.